We capture recent findings in the field of genetic epidemiology of eating disorders. As analytic techniques evolve for twin, population, and molecular genetic studies, new findings emerge at an accelerated pace. We present the current status of knowledge regarding the role of genetic and environmental factors that influence risk for eating disorders.
INTRODUCTION
Genetic epidemiology has been transformative in our understanding of how genes and environmental factors contribute to the emergence of eating disorders such as anorexia nervosa, bulimia nervosa, and binge-eating disorder (BED). Forming the foundation of this knowledge base are large twin studies establishing that all three disorders are heritable. Replicated twin-based heritability estimates for anorexia nervosa range between 0.48 and 0.74, for bulimia nervosa between 0.55 and 0.62, and for BED between 0.39 and 0.45 [1] . Although all of these studies have been conducted on European-ancestry populations, results have converged to support the role of genetic factors in the etiology of these conditions.
In this review, we focus on novel findings from twin studies, population studies using informative genetic designs, and molecular genetic studies with a full-genome approach that bring us to the current state of understanding of eating disorders. For the purpose of this review, we focus on studies of diagnostic categories and component behaviors rather than broader related phenotypes such as body dissatisfaction, disordered eating, and weight and shape concerns.
RECENT INSIGHTS FROM TWIN AND POPULATION STUDIES
Genetic and environmental contributions to DSM-5 eating disorder phenotypes Previous twin-based heritability estimates for eating disorders were determined based on Diagnostic and Statistical Manual of Mental Disorders (DSM) III-R or IV criteria. Studies are emerging that explore these parameters in DSM-5-defined eating disorders. In a longitudinal study of Finnish female twins, the lifetime prevalence of anorexia nervosa increased from 2.2 to 3.6% with the introduction of DSM-5 criteria (vs. DSM-IV diagnoses in the same group). DSM-5 cases were, on average, less severe, with significantly later age of onset, higher minimum body mass index (BMI), shorter duration of illness, and higher 5-year probability of recovery [2] . DSM-5 also introduced the category of unspecified feeding and eating disorders (UFEDs). Adolescent females in the Australian Twin Registry who were labeled as having the 'restricting and/or exercise disorders' variant of UFED reported eating disorder severity [measured via Eating Disorder Examination (EDE) global score] and clinical impairment/distress that were on par with individuals meeting criteria for anorexia nervosa or atypical anorexia nervosa -and significantly greater than the noneating disorder group [3] . This observation underscores the importance of making treatment available for individuals with UFED.
Influence of genes and environment on other eating disorder phenotypes
In the first study to examine familial liability to purging disorder, familial effects (both additive genetic and shared environmental effects) accounted for 44% of the phenotypic variance in purging disorder among European-American twins in the Missouri Adolescent Female Twin Study, whereas 56% was ascribed to nonshared environmental factors. Because of insufficient sample size and low prevalence, researchers were unable to distinguish between genetic and environmental familial effects [4] .
In further explorations of genetic and environmental contributions to purging, it was found that self-induced vomiting (SIV) is a highly-heritable behavior common to several eating disorder diagnoses. However, how genetic and environmental factors influenced SIV initiation (ever engaging in SIV) vs. SIV progression (regularly engaging in SIV) was previously unknown. With data from the Swedish Twin study of Adults: Genes and Environment, researchers found that the majority of genetic and environmental factors (83%) were shared between SIV initiation and progression, and that 100% of the genetic liability to SIV progression was shared with SIV initiation. However, a small proportion of variance in SIV progression is unique and can be attributed to both shared and unshared environmental factors [5 & ].
In a large register-based study of a youth cohort in Stockholm, Sweden, when one or both parents had a lifetime history of psychiatric illness (in particular, bipolar affective disorder, personality disorder, anxiety, or depression), offspring were at increased risk of developing an eating disorder [6] . No evidence for increased risk was found for parental substance use disorder, schizophrenia, or somatoform illnesses.
Psychiatric comorbidity and suicide
In a study using the National Patient Register in Sweden, which included (i) 19,814 individuals with obsessive-compulsive disorder (OCD) and 8,462 individuals with AN. (ii) Their first-, second-and third-degree relatives. (iii) Population-matched comparison individuals and their relatives, the risk of having anorexia nervosa in those with OCD was 16-fold greater in females and 37-fold greater in males. Individuals first diagnosed with OCD were at significantly elevated risk for a later diagnosis of anorexia nervosa (risk ratio ¼ 53.6), and the reverse also held true (risk ratio ¼ 59.6). First-degree and second-degree relatives of individuals with OCD were at increased risk for anorexia nervosa, and the magnitude of risk increased in proportion to the degree of genetic relatedness. An analysis of female twins (N ¼ 8550) revealed a moderate but significant genetic correlation between self-reported OCD and anorexia nervosa diagnoses [r a ¼ 50.52, 95% confidence interval (CI): 0.26-0.81]. This observation supports that the frequently observed comorbid pattern of anorexia nervosa and OCD is at least in part due to shared genetic factors, although disorderspecific genetic factors are also operative [7 & ].
In the Missouri Adolescent Female Twin Study, common genetic mechanisms were also found for underlying liability to alcohol use disorder and
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bulimic behaviors in both European-American and African-American twins [8 & ]. However, familial liability (whether genetic or environmental) was not the only operative factor. In a subsequent analysis of 53 pairs of monozygotic twins who were discordant for early alcohol experimentation (i.e., use prior to age 15), those who experimented early had greater odds of reporting bulimic behaviors than co-twins without early experimentation [odds ratio (OR) ¼ 3.12, 95% CI: 1.54-6.67]. Given that monozygotic twins share, on average, 100% of their segregating alleles, this pattern of results suggests a role for individual-specific environmental risk factors for bulimic behaviors [9] .
Individuals with eating disorders are known to be at increased risk for suicide, but the nature of the relationship between the two phenotypes has been, until now, unknown [10] . Two twin studies explored the relation among eating disorders, depression, and suicidality. Using the Australian Twin Registry, researchers reported that an eating disorder diagnosis (anorexia nervosa, bulimia nervosa, BED, or purging disorder) was associated with a two-fold increase in suicidality and that common genetic factors underly a combined eating disorders phenotype (anorexia nervosa, bulimia nervosa, BED, and purging disorder) and suicidality (r a ¼ 0.60, 95% CI: 0.25-1.00), as well as major depressive disorder (MDD) and suicidality (r a ¼ 0.65, 95% CI: 0.43-0.87) -but not eating disorders and MDD [11] . A similar study in Sweden revealed shared genetic risk for anorexia nervosa and suicide attempts (r a ¼ 0.52, 95% CI: À0.14 to 1.00), anorexia nervosa and MDD (r a ¼ 0.49, 95% CI: 0.18-1.00), and MDD and suicide attempts (r a ¼ 0.77, 95% CI: 0.45-1.00) [12 & ]. Finally, a Swedish population study (N ¼ 2 268 786) reported significantly increased risk of suicide attempts among individuals with eating disorders and among individuals without eating disorders who had a relative with an eating disorder, even after accounting for the effects of psychiatric comorbidity [13 && ]. This pattern of familial co-aggregation suggests familial liability for the association between eating disorders and suicide. Together, these three studies not only underscore the concerning elevated risk for suicide in individuals with eating disorders, but also confirm that the pattern may be due to familial factors that may be genetic in origin.
Other observations from genetic epidemiology
When examining genetic risk for MDD and overeating-binge eating behavior (OE-BE; i.e., binge eating along with loss of control) in female European-American and African-American twins in the Missouri Adolescent Female Twin Study, additive genetic influences accounted for 44% (95% CI: 34-53%) of the MDD phenotypic variation and 40% (95% CI: 25-54%) for OE-BE, with the remaining variances due to nonshared environmental influences. Genetic overlap was substantial (r g ¼ 0.61, 95% CI: 0.39-0.85), and nonshared environmental influences were more weakly correlated (r e ¼ 0.26, 95% CI: 0.09-0.42), suggesting that some of the genetic and nonshared environmental factors that influence liability to MDD also influence vulnerability to OE-BE [14] . Estimates were similar in European-American and African-American twins.
Observations from a Swedish national cohort (N ¼ 1 800 643) revealed that the previously reported association between high school achievement and eating disorders could be explained by unmeasured familial confounders (whether genetic or environmental), with associations disappearing as the proportion of shared genes/environment increased (from first cousins to half siblings to full siblings to monozygotic twins) [15] .
RECENT INSIGHTS FROM MOLECULAR GENETIC STUDIES
To date, numerous small-scale candidate gene studies have been carried out to explore the molecular genetic etiology of eating disorders, yielding variable findings that failed to replicate reliably [1] . Recent advances in technology and the decreased cost of genomic experiments now allow for millions of loci to be examined simultaneously in large numbers of individuals through methods such as genome-wide association studies (GWASs), highthroughput exome, and whole-genome sequencing. In this review, we summarize recent eating disorders genetic research with a genome-wide focus.
Genome-wide association studies
The first anorexia nervosa GWAS was notably underpowered to detect genome-wide significant loci [16] . A somewhat larger, yet still underpowered, anorexia nervosa GWAS was conducted under the umbrella of the Genetic Consortium for Anorexia Nervosa (GCAN), funded by the Wellcome Trust Case Control Consortium 3. The analysis included 2907 cases and 14 860 ancestry-matched controls. Although there were no genome-wide significant hits reported, 72 independent markers with the lowest P-values were selected for replication, and 76% of these loci produced results in the same direction as the discovery sample in an independent replication Genetic epidemiology of eating disorders Bulik et al.
sample. These results provided a strong indication that the prioritized set of genomic variants likely contained true positive signals for anorexia nervosa risk and that increased sample sizes would be likely to yield significant associations [17] .
Eating disorders are notably prevalent in individuals with bipolar disorder [18] . A GWAS of 184 bipolar cases with comorbid eating disorders (anorexia nervosa or bulimia nervosa), 2006 bipolar cases without an eating disorder, and 1370 controls did not yield any genome-wide significant findings, but the top hits associated with comorbid eating disorders were located in the SOX2 overlapping transcript (SOX2-OT) gene on chromosome 3 [19] . This finding is of interest because the anorexia nervosa GWAS by Boraska et al. [17] also reported a suggestive (but not genome-wide significant) association between SOX2-OT and anorexia nervosa (peak P ¼ 3.0 Â 10 À7 ).
Although not an eating disorder per se, 'food addiction' as measured by the Yale Food Addiction Scale [20] has been associated with binge-eating episodes, hedonic eating, emotional eating, impulsivity, and food and snack craving, as well as patterns of neural response implicated in other addictive disorders, and has been previously studied in the context of BED [21, 22] . In a subset of 9314 women enrolled in the Nurses' Health Study and Nurses' Health Study II, two genome-wide significant loci were associated with food addiction traits. Specifically, an intronic variant in the protein kinase C, alpha (PRKCA) gene and an intronic variant in the neurotrimin (NTM) gene reached genome-wide significance for measures of food addiction. Although PRKCA has been previously associated with BMI through linkage [23] , NTM is shown to be closely linked to opioid system genes [24] . Furthermore, the authors reported enrichment in the mitogen-activated protein kinase (MAPK) signaling pathway genes -previously identified as a candidate drug addiction pathway [25] -for food addiction accompanied with clinically significant impairment and distress. Of note, there was no association between food addiction and previously identified top 32 BMI loci [26] . Although these findings do not provide convincing support for shared genetic determinants of food addiction and drug addiction, results must be interpreted in the context of incomplete knowledge of the genetic architecture of drug addiction and the absence of replication of the food addiction GWAS [27] .
Genetic correlation between anorexia nervosa and other psychiatric disorders
Cross-disorder analyses of psychiatric disorders have provided strong evidence for shared etiology among schizophrenia, bipolar disorder, MDD, autism spectrum disorder, and attention deficit/ hyperactivity disorder [28, 29] . The recent development of an analytic method called LD Score Regression (LDSC), which accounts for linkage disequilibrium (LD) for each marker while estimating heritability, allows for speedy calculation of genetic correlation between different phenotypes and traits using GWAS summary statistics and is not biased by sample overlap [30] .
Through the application of LDSC to anorexia nervosa GWAS data and various publicly available consortia data, a strong positive genetic correlation between anorexia nervosa and schizophrenia was reported (r g ¼ 0.19, SE ¼ 0.04, P ¼ 2 Â 10 À5 ), which means that the common variants cumulatively associated with schizophrenia risk also increase risk for anorexia nervosa. Additionally, positive genetic correlations of smaller magnitude were observed between anorexia nervosa and bipolar disorder, as well as anorexia nervosa and MDD [31 && ]. Taken together, these results further highlight the shared genetic architecture and the important role of common variation in the etiology of anorexia nervosa and other psychiatric disorders, and these findings are in line with the highly observed comorbidity among psychiatric disorders.
Genetic correlation between anorexia nervosa and nonpsychiatric phenotypes
Bulik-Sullivan et al. [30] examined the genetic correlation between anorexia nervosa and various medical phenotypes and anthropometric traits. The most significant genetic correlation for anorexia nervosa was observed with BMI, which was in the negative direction (r g ¼ À0.18, SE ¼ 0.04, P ¼ 3 Â 10 À7 ). An inverse genetic correlation of similar magnitude was also reported for anorexia nervosa and adult obesity, providing evidence for the possible involvement of metabolic pathways in the etiology of anorexia nervosa. Other notableeven though nonsignificant -genetic correlations with anorexia nervosa included childhood obesity (negative), smoking (negative), years of education (positive), infant head circumference (negative), high-density lipoprotein cholesterol (positive), and rheumatoid arthritis (negative) [31 && ].
Copy number variation
Copy number variation is characterized by a change in the number of copies of a genomic region, either in the form of deletions or duplications. The only genome-wide copy number variant (CNV) study of eating disorders utilized the same dataset as the first anorexia nervosa GWAS, and researchers reported a 1.4 Mb deletion on 13q12 in two anorexia nervosa cases [16] . More recently, in the largest anorexia nervosa case-only CNV study to date, one individual also presented with a deletion which had 80% reciprocal overlap with the 13q12 deletion. Of note, multiple reports of this CNV exist in public CNV databases for phenotypes unrelated to anorexia nervosa or psychiatric disorders; thus, there is currently no strong evidence for 13q12 deletion being an anorexia nervosa-specific risk CNV (Yilmaz et al., personal communication).
High-throughput sequencing
To date, only two high-throughput sequencing studies have been published in eating disorders.
In the first study, Scott-Van Zeeland et al. [32] reported associations involving estrogen receptor 2 (ESR2) and epoxide hydrolase 2 (EPHX2) in anorexia nervosa through targeted candidate gene sequencing. Case-control allele frequency differences for variants in these two genes were also observed in an anorexia nervosa GWAS dataset [16] . EPHX2 was shown to be associated with depression and anxiety in a subgroup of anorexia nervosa cases, as well as BMI and elevated cholesterol in a large longitudinal population cohort [32] . The second high-throughput sequencing study identified and analyzed genetic mutations that segregated with eating disorders in two families with multiple members affected with anorexia nervosa or bulimia nervosa. Linkage analysis followed by wholegenome sequencing revealed a missense mutation in the estrogen-related receptor alpha (ESSRA) gene in the first pedigree. In the second pedigree, a potentially deleterious rare mutation in the histone deacetylase 4 (HDAC4) gene was identified through exome sequencing. Immunoprecipitation experiments in HeLa cells and mouse cortices demonstrated functional interaction between ESRRA and HDAC4, and using transcriptional activity assays, researchers reported that HDAC4 might act as an inhibitor of ESRRA activity [33] .
Epigenetics
In 29 acutely ill patients with anorexia nervosa and 15 women without disordered eating, increased global methylation was observed in anorexia nervosa cases compared with controls, while no differences in global methylation between anorexia nervosa restricting and binge-eating/purging subtypes were detected [34] . After combining anorexia nervosa subtypes, methylation differences between cases and controls were especially pronounced for genes associated with histone acetylation and RNA modification, cholesterol storage and lipid transport, dopamine and glutamate signaling, and metabolism and weight loss. Some of the probes that correlated significantly with anorexia nervosa age of onset were associated with methylation of genes involved in brain and spinal cord development, hair growth, and development/maintenance of skin and teeth. Similarly, anorexia nervosa age of onset was associated with gene pathways involved in brain development. Researchers also observed a significant correlation between anorexia nervosa duration of illness and methylation levels at probes for genes related to the immune system, liver function, and metabolism, as well as gene pathways associated with anxiety, social functioning, bowel dysfunction, immune function, and liver damage -symptoms commonly reported in patients with anorexia nervosa. Although preliminary and based on a small sample, the results of this pilot study suggest that anorexia nervosa -especially if enduring or with early onset -could significantly alter the expression of genes associated with various metabolic, physical, and psychological functions, disruptions in which are some of the key medical and psychiatric complications of anorexia nervosa.
CONCLUSION
Studies of the genetic epidemiology of eating disorders are advancing at pace with evolving technology and methodology. The next decade promises to yield significant results that will further reveal the nature, magnitude, and specificity of genetic and epigenetic contributions to the etiology of these pernicious illnesses. Funding for genetic studies of anorexia nervosa has surpassed that for bulimia nervosa, BED, and other eating disorders, meaning that our understanding of those disorders lags woefully behind. Future work adhering to the highest standards of science, and that includes adequate sample sizes and replication, is essential to advancing the science of eating disorders.
